Martin Engel
Scientific and Medical Partnership Lead Neurizon
Dr. Martin Engel is an experienced strategic lifescience partnership manager with strong expertise in neuropharmacology. In his role as Medical & Scientific Partnerships Lead at Neurizon, he drives global engagement with pharmaceutical partners, supporting scientific due diligence, shaping program positioning, and providing input to clinical and pre-clinical development planning aligned with partner expectations. Martin brings a proven ability to work across clinical, pre-clinical, and commercial teams, with a track record of building trusted external relationships across US, EU and APAC, and representing organisations in scientific and industry forums; he holds a PhD in neuropharmacology and has published widely on treatment development across central nervous system disorders.
Seminars
2nd Presentation Session
Present your company’s slides by securing a 15-minute presentation slot in front of the attending audience.
What is this session?
To host as many innovative companies as possible on day one, this second session opens more presenting opportunities in front of the attending audience.
Presentation Sessions Remaining
3.15 – Tinostamustine, a Novel Approach for the Treatment of Central Nervous System Cancers Presentation by Imbrium Therapeutics
3.30 – Improved BBB Transport via Novel AAV Capsid Engineered to Bind to TfR1 Receptor Presentation by Exegenesis Bio
3.45 – The Opportunity for Neflamapimod in Age-Related Brain Disorders Presentation by CervoMed
4.00 – NUZ-001: An Investigational Oral Therapy in Phase 2/3 Clinical Development for ALS by Neurizon
4.15 – Reimagining Levodopa Therapy with Minitablets & the OraFID Device by Navamedic
4.30 – Risvodetinib as a Potential Disease Modifying Therapy for Neurodegenerative Disease by ABLi Therapeutics
4.45 – Presentation by Agene Bio
5.00 – Presentation by Senovia Bioscience
5.15 – Why Short Lipidated Peptidomimetics (SLiPs) Could Change the World for Patients with Chronic Pain Presentation by Mimetic Medicines
